📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LLYVA.
💹 Market Data
Market Cap$8.75B
Shares Outstanding25.57M
FloatN/A
Cash$524.43M
Debt$1.82B
Short InterestN/A
🏛 Institutional Holdings
259 institutional holders · 63.90M shares
#1
T. Rowe Price Investment Management, Inc.
13.81M shares
#2
Berkshire Hathaway Inc
10.92M shares
#3
Linonia Partnership LP
5.75M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest875.6K
Days to Cover8.8
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
8-K
8K EVENT
Mar 13, 2026
4
INSIDER TRANSACTION
Mar 09, 2026
4
INSIDER TRANSACTION
Mar 09, 2026
4
INSIDER TRANSACTION
Mar 09, 2026
4
INSIDER TRANSACTION
Feb 23, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LLYVA
📊 LLYVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LLYVA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.